EndocrineICD-10: E11.9Affects approximately 37 million Americans (about 1 in 10)

Type 2 Diabetes

Also known as: T2D, Adult-Onset Diabetes, Non-Insulin-Dependent Diabetes, Type 2 Diabetes Mellitus

Type 2 diabetes is a chronic metabolic condition characterized by insulin resistance and relative insulin deficiency, leading to elevated blood sugar levels. It accounts for 90-95% of all diabetes cases and is strongly associated with obesity, physical inactivity, and genetic factors. While type 2 diabetes is a progressive condition, it can often be managed or even put into remission through lifestyle modifications, medications, and regular monitoring.

Last updated October 31, 2026

Understanding Type 2 Diabetes

Type 2 diabetes is a condition in which blood glucose stays high because the body no longer responds properly to insulin and the pancreas can no longer make enough to compensate. It is diagnosed when HbA1c, a three-month average of blood glucose, reaches 6.5 percent, or fasting glucose reaches 126 mg/dL (7.0 mmol/L) on two occasions. About 38 million Americans have it, roughly one in four of them undiagnosed, and worldwide the number has quadrupled since 1980. It is better understood as a cardiometabolic disease than a sugar disease: the glucose is the visible marker, but the same insulin resistance also drives high blood pressure, abnormal cholesterol, fatty liver and a two- to fourfold increase in heart attacks and strokes. Unlike type 1, it is not autoimmune, and in its early years it is often fully reversible.

Insulin is the hormone that tells muscle to take up glucose, fat to store energy and the liver to stop releasing glucose. In type 2 diabetes, excess fat stored where it does not belong, inside the liver and around the pancreas, blunts those signals. The liver keeps pouring out glucose overnight, which is why fasting readings rise first. The pancreas compensates by producing more insulin for years, but by the time of diagnosis beta-cell output is already down by about half, and without intervention it declines a further 4 percent a year. Chronically high glucose then damages blood vessels directly: it glycates proteins, generates oxidative stress and injures the lining of capillaries in the retina, kidney filters and nerves (microvascular disease), while accelerating plaque in the arteries of the heart, brain and legs (macrovascular disease).

Left alone, type 2 diabetes is progressive, and most people need more treatment over time. Modern care targets an HbA1c below 7 percent for most adults, individualized for age and frailty, and treats blood pressure and cholesterol with equal seriousness because they drive most of the deaths. Metformin remains first-line: it lowers HbA1c by 1 to 1.5 points, does not cause weight gain or hypoglycemia, costs pennies, and in the UKPDS reduced death in overweight patients by 36 percent, though it causes gut upset in a fifth of users and can lower vitamin B12. SGLT2 inhibitors (empagliflozin, dapagliflozin) lower HbA1c modestly but cut heart failure admissions by about 30 percent and slow kidney decline. GLP-1 receptor agonists (semaglutide, dulaglutide) lower HbA1c by 1 to 1.5 points, produce 10 to 15 percent weight loss and reduce cardiovascular events by 13 to 26 percent; nausea, cost and rare pancreatitis are the trade-offs. Sulfonylureas and insulin work but cause hypoglycemia and weight gain.

The most powerful natural approach is not a capsule. In the UK DiRECT trial, 46 percent of people diagnosed within the previous six years who followed a structured low-calorie diet achieved remission at one year without medication, rising to 86 percent among those who lost 15 kg or more, and 36 percent were still in remission at two years. Supplements are adjuncts to that, and to medication. Berberine has the strongest glucose data, lowering HbA1c by roughly 0.7 to 0.9 points in trials and matching metformin in small head-to-head studies; psyllium, magnesium (if you are low) and cinnamon produce smaller improvements; alpha-lipoic acid helps the symptoms of diabetic nerve pain rather than glucose; chromium and gymnema are weaker, and vitamin D does not improve HbA1c unless you are deficient. Most trials are short, small and of modest quality. The crucial safety point is stacking: berberine, cinnamon, chromium or gymnema on top of a sulfonylurea or insulin can cause hypoglycemia, so monitor and tell your doctor before you start.

The thing most people get wrong is treating type 2 diabetes as a disease of sugar intake to be managed by avoiding dessert. It is a disease of energy storage, and the lever that moves it most is total body fat, especially the few kilograms inside the liver and pancreas, which is why a 15 percent weight loss can switch it off while a sugar-free diet at the same weight cannot. A related error is thinking a 'mild' diabetes with an HbA1c of 7 percent needs no action: the UKPDS follow-up showed that good control in the first decade keeps paying off twenty years later, the so-called legacy effect, and damage to the eyes, kidneys and nerves begins in that mild phase. Finally, starting insulin or a GLP-1 drug is not a failure; it is often the fastest route to the weight and glucose control that make remission possible.

At a Glance

Common symptoms
Increased thirst and dry mouth, Frequent urination, Increased hunger
Main treatments
Lifestyle modifications (healthy diet, regular exercise, weight loss), Metformin (first-line oral medication), SGLT2 inhibitors (empagliflozin, dapagliflozin) with cardiovascular and renal benefits
Category
Endocrine · Affects approximately 37 million Americans (about 1 in 10)
See a doctor if
You have risk factors for diabetes and have not been screened

Symptoms

Increased thirst and dry mouth
Frequent urination
Increased hunger
Fatigue
Blurred vision
Slow-healing wounds or frequent infections
Numbness or tingling in hands and feet (peripheral neuropathy)
Areas of darkened skin (acanthosis nigricans)
Unexplained weight loss (in some cases)

Causes

  • Insulin resistance (cells don't respond properly to insulin)
  • Progressive beta-cell dysfunction in the pancreas
  • Genetic predisposition
  • Excess body fat, especially visceral (abdominal) fat
  • Sedentary lifestyle

Risk Factors

  • Overweight or obesity (BMI ≥ 25)
  • Physical inactivity
  • Family history of type 2 diabetes
  • Age 45 and older
  • African American, Hispanic, Native American, or Asian American ancestry
  • History of gestational diabetes or prediabetes

Diagnosis

  • HbA1c test (≥6.5% indicates diabetes; 5.7-6.4% indicates prediabetes)
  • Fasting plasma glucose (≥126 mg/dL)
  • Oral glucose tolerance test (≥200 mg/dL at 2 hours)
  • Random plasma glucose (≥200 mg/dL with symptoms)

Treatment

  • Lifestyle modifications (healthy diet, regular exercise, weight loss)
  • Metformin (first-line oral medication)
  • SGLT2 inhibitors (empagliflozin, dapagliflozin) with cardiovascular and renal benefits
  • GLP-1 receptor agonists (semaglutide, liraglutide) for glucose control and weight loss
  • Other oral agents (sulfonylureas, DPP-4 inhibitors, thiazolidinediones)
  • Insulin therapy when oral medications are insufficient

Natural remedies for type 2 diabetes: what the evidence says

Ranked by the strength of human evidence for type 2 diabetes specifically. These sit alongside medical care, not in place of it.

  1. Berberine

    Strong evidence

    In a pilot trial of 36 newly diagnosed adults, berberine 500 mg three times daily for three months lowered HbA1c from 9.5 to 7.5 percent, matching metformin 500 mg three times daily; as an add-on in 48 poorly controlled patients it lowered HbA1c from 8.1 to 7.3 percent. A 116-patient placebo-controlled trial of 1 g daily lowered HbA1c from 7.5 to 6.6 percent and fasting glucose by 30 mg/dL, and meta-analyses of over 20 mostly Chinese trials find reductions of 0.7 to 0.9 points. Trials last 8 to 13 weeks; longer-term data are lacking.

    Studied dose
    500 mg two to three times daily with meals (1,000 to 1,500 mg per day), for at least 12 weeks; take with food to limit stomach upset.
    Cautions
    Can cause hypoglycemia when added to sulfonylureas, meglitinides or insulin, so monitor glucose and ask about dose reduction. Inhibits CYP3A4, CYP2D6 and P-glycoprotein, raising levels of cyclosporine, simvastatin, metoprolol and others; avoid in pregnancy, breastfeeding and newborns (risk of jaundice); may cause constipation.
  2. The evidence is for diabetic nerve pain, not glucose. In the SYDNEY 2 trial, 181 people with painful diabetic neuropathy took 600, 1,200 or 1,800 mg daily for five weeks; symptom scores fell 51 percent on 600 mg versus 32 percent on placebo, with higher doses adding side effects but not benefit. A meta-analysis of four trials of intravenous 600 mg for three weeks found a clinically meaningful improvement in pain and numbness. The four-year NATHAN 1 trial of 600 mg oral showed slowed progression of nerve deficits but missed its primary endpoint.

    Studied dose
    600 mg once daily on an empty stomach, 30 minutes before breakfast, for at least five weeks; higher doses add nausea without extra benefit.
    Cautions
    ALA lowers blood glucose modestly and can potentiate insulin and sulfonylureas; rarely it triggers insulin autoimmune syndrome with severe hypoglycemia, mostly in people of East Asian ancestry. It may interfere with thyroid hormone and should be taken apart from levothyroxine; stop before surgery.
  3. Psyllium Husk

    Moderate evidence

    A 2015 meta-analysis of 35 trials found psyllium's effect scales with how high glucose is: in people being treated for type 2 diabetes, about 10 g daily before meals lowered fasting glucose by 37 mg/dL and HbA1c by 0.97 points, while people with normal glucose saw no change. The data come from a handful of trials of 8 to 20 weeks, so the effect size may be generous, but the mechanism (slowing carbohydrate absorption) is well established and it lowers LDL at the same time.

    Studied dose
    3.4 to 5 g psyllium husk in 250 mL water immediately before two to three meals (10 to 15 g per day).
    Cautions
    Separate from metformin, levothyroxine, carbamazepine and other medicines by at least two hours as it reduces their absorption. Always take with plenty of water; avoid with swallowing difficulty or bowel obstruction. Expect lower post-meal readings and adjust insulin with your care team.
  4. Cinnamon

    Moderate evidence

    A 2013 meta-analysis of 10 randomized trials in 543 adults with type 2 diabetes found cinnamon at 120 mg to 6 g daily for 4 to 18 weeks lowered fasting glucose by 25 mg/dL, total cholesterol by 16 mg/dL and triglycerides by 30 mg/dL, but did not significantly change HbA1c. Later meta-analyses report HbA1c reductions of 0.3 to 0.5 points when trials ran longer than 12 weeks. Results vary widely between studies, and the 2012 Cochrane review found no reliable effect.

    Studied dose
    1 to 3 g per day of Ceylon cinnamon (Cinnamomum verum) powder or capsules with meals; prefer Ceylon over cassia for long-term use because of coumarin content.
    Cautions
    Cassia cinnamon contains coumarin, which can damage the liver at 1 teaspoon a day or more, particularly with liver disease or hepatotoxic drugs. Cinnamon adds to glucose lowering from sulfonylureas and insulin; monitor for hypoglycemia.
  5. Magnesium Glycinate

    Moderate evidence

    Up to a third of people with type 2 diabetes have low magnesium, which worsens insulin resistance. In a 16-week placebo-controlled trial of 63 diabetics with low magnesium, 300 mg of elemental magnesium daily (as magnesium chloride solution) improved fasting glucose, HbA1c and insulin sensitivity significantly more than placebo. A 2016 meta-analysis of 18 trials found improvements in fasting glucose and insulin sensitivity in people with diabetes or at risk, with little effect in those already replete.

    Studied dose
    250 to 400 mg elemental magnesium per day as glycinate with food, after checking serum magnesium, for at least three to four months.
    Cautions
    Do not supplement in moderate to severe kidney disease, where magnesium accumulates. Space two hours from quinolone or tetracycline antibiotics, levothyroxine and bisphosphonates. SGLT2 inhibitors can raise magnesium slightly; diuretics and metformin lower it.
  6. Chromium

    Moderate evidence

    A 2014 meta-analysis of 22 trials found chromium supplements lowered HbA1c by 0.6 points and fasting glucose by 19 mg/dL in type 2 diabetes, with chromium picolinate more effective than other forms. However the trials are inconsistent: a well-known Chinese trial of 1,000 mcg daily reported HbA1c falling from 8.5 to 6.6 percent in four months, while several Western trials found no effect, and the American Diabetes Association does not recommend it for people without deficiency.

    Studied dose
    Chromium picolinate 200 to 1,000 mcg per day with meals for at least three to four months; higher doses used in trials are above usual dietary intake.
    Cautions
    May cause hypoglycemia with insulin or sulfonylureas. Rare case reports of kidney and liver injury at high doses; separate from levothyroxine by three to four hours; NSAIDs increase absorption and corticosteroids increase loss.
  7. Gymnema

    Preliminary evidence

    Gymnema sylvestre has a long Ayurvedic history and animal data suggesting it supports insulin secretion, but human evidence rests on small, mostly uncontrolled studies. In a 1990 open study, 22 people with type 2 diabetes taking 400 mg of extract daily alongside oral drugs for 18 to 20 months saw HbA1c fall from 11.9 to 8.5 percent and five stopped medication, but there was no placebo group. A 2024 meta-analysis of small trials found modest reductions in fasting glucose. It is not a substitute for proven treatment.

    Studied dose
    400 mg per day of a standardized leaf extract (such as GS4, 25 percent gymnemic acids) in divided doses with meals.
    Cautions
    Additive glucose lowering with sulfonylureas and insulin; monitor closely. No safety data in pregnancy or breastfeeding. Rare reports of liver injury with Ayurvedic blends, so buy from a tested brand.
  8. Vitamin D

    Preliminary evidence

    Low vitamin D is common in type 2 diabetes but correcting it rarely moves glucose. Meta-analyses of around 20 trials find supplementation lowers HbA1c by only 0.1 to 0.3 points, with any benefit confined to people who were deficient (below 20 ng/mL) and short trials. Large prevention trials in prediabetes (D2d, 4,000 IU daily, 2,423 adults) showed no significant reduction in progression. Worth correcting a deficiency for bone and general health, not as a glucose treatment.

    Studied dose
    1,000 to 2,000 IU vitamin D3 daily, or more under supervision, aiming for a blood 25-hydroxyvitamin D above 30 ng/mL (75 nmol/L); test first.
    Cautions
    Doses above 4,000 IU daily without monitoring risk high calcium, especially with thiazide diuretics or calcium supplements. Avoid high doses in sarcoidosis, hyperparathyroidism or kidney stones.

What matters day to day

  • Lose weight if you can: in DiRECT, 46 percent of recently diagnosed patients achieved drug-free remission at one year, and 86 percent of those who lost 15 kg or more; even 5 to 10 percent loss lowers HbA1c by about 0.5 to 1 point.
  • Combine aerobic and resistance exercise: structured training lowered HbA1c by 0.67 points in a meta-analysis of 47 trials, and more than 150 minutes a week lowered it by 0.89; a 10 to 15 minute walk after each meal blunts the post-meal glucose spike better than one long walk.
  • Build meals around fiber, protein and unsaturated fat and limit refined starch and sugary drinks; Mediterranean and low-carbohydrate patterns both lower HbA1c by 0.3 to 0.5 points, and the one you can sustain is the right one.
  • Protect sleep: under six hours a night increases insulin resistance measurably within days, and obstructive sleep apnea, present in over half of obese people with type 2 diabetes, raises HbA1c when untreated.
  • Stop smoking: smokers with diabetes have a 30 to 40 percent higher risk of cardiovascular death and faster kidney decline, and quitting does more for lifespan than most glucose drugs.
  • Keep the annual checks: eyes (retinal photography), feet (sensation and pulses), kidneys (urine albumin) and cholesterol, because each complication is far easier to halt early than to treat late.

Prevention

  • Lose 5-7% of body weight if overweight or obese
  • Engage in at least 150 minutes of moderate exercise per week
  • Follow a balanced diet emphasizing whole grains, vegetables, and lean protein
  • Limit sugary beverages and processed foods
  • Get screened regularly if you have prediabetes or risk factors

When to See a Doctor

  • You have risk factors for diabetes and have not been screened
  • You experience increased thirst, frequent urination, or unexplained fatigue
  • Your blood sugar is consistently above target despite medication
  • You develop numbness in your feet, vision changes, or slow-healing wounds

Frequently Asked Questions

References

  1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet (1998)View source
  2. Lean MEJ, Leslie WS, Barnes AC, et al.. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet (2018)View source
  3. Lean MEJ, Leslie WS, Barnes AC, et al.. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes & Endocrinology (2019)
  4. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism (2008)View source
  5. Zhang Y, Li X, Zou D, et al.. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology & Metabolism (2008)
  6. Ziegler D, Ametov A, Barinov A, et al.. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care (2006)
  7. Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Annals of Family Medicine (2013)
  8. Gibb RD, McRorie JW, Russell DA, Hasselblad V, D'Alessio DA. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. American Journal of Clinical Nutrition (2015)
  9. Umpierre D, Ribeiro PA, Kramer CK, et al.. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA (2011)
  10. Marso SP, Daniels GH, Brown-Frandsen K, et al.. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER). New England Journal of Medicine (2016)View source

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Type 2 Diabetes. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Related Reading

Have questions about Type 2 Diabetes?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.